Skip to main content
. 2018 Jun 6;5(3):290–299. doi: 10.1016/j.gendis.2018.05.004

Figure 3.

Figure 3

Effects of rosiglitazone (Rosi) or CMHX008 (CMHX) treatment on phosphorylation of PPARγ (p-PPARγ), insulin receptor (p-IR) and Akt (p-Akt). Representative Western blots of protein phosphorylation (A, B, C) in white adipose tissue. Bar graphs show the p-PPARγ, p-IR and p-Akt levels normalized to total appropriate protein levels.*P < 0.05, **P < 0.01 versus Veh, #P < 0.05 versus Rosi (n = 7/group).